公司資料
Kodiak Sciences 股價、新聞與催化劑
- 股票代碼:
- KOD
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
37.22 USD (-2.90%)
收盤價
最後更新: 2026年8月24日
2.08B USD
市值
股價為何變動
As of Aug 24, 2026, KOD closed down 2.90% at $37.22. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Kodiak Sciences is a retinal-disease company focused on ophthalmology and long-duration eye therapies. Its story has been shaped by the challenge of building a differentiated retina franchise.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Kodiak sits in specialty ophthalmology biotechnology.
商業模式特徵
The company depends on clinical data, delivery strategy, and the ability to create a durable retinal-disease platform.
生技產業定位
Kodiak is a high-beta eye-care name with strong sensitivity to data and execution risk.
未來催化劑
- Kodiak is now mostly a legacy and transaction-closeout name, so the catalysts are any final ophthalmology or strategic milestones that clarify remaining value. The market is not treating it like a fresh growth story anymore.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。